cmRNAbone

3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients

Programme
Horizon 2020 & sub-programmes
Duration
54 months (January 2020 – June 2024)
Project funding
≈ €6 million
Project partners
11
Technology readiness level
4-7
Project website
Visit project website

What the project is about

The cmRNAbone project aim to create a novel bone regenerative therapeutic approach based on combination of chemically modified RNAs (cmRNAs)-vectors embedded in a 3D-printed guiding biomaterial ink tailored to patients need.

Coordinator

Prof. Martin Stoddart

AO Research Institute Davos, Switzerland

Email coordinator

Your EURICE contacts

Explore THE COURT

Discover THE COURT, the EURICE environment where projects, expertise and partners connect across six innovation ecosystems.

Enter THE COURT